A Study to Evaluate Vaginal Versus Intramuscular Progesterone for Prevention of Recurrent Spontaneous Preterm Birth

Official Title: Vaginal Versus Intramuscular Progesterone for Prevention of Recurrent Spontaneous Preterm Birth (VIP)

Purpose:

The purpose of this study is to compare the effectiveness of vaginal progesterone vs. intramuscular progesterone for the prevention of recurrent spontaneous preterm birth.

Eligibility criteria:

- Pregnant women with a single fetus
- 18 years and older with an estimated gestational age less than 24 weeks and
- Have had a prior spontaneous preterm birth of a single fetus between 16 weeks and 36 weeks and 6 days
- Have not already begun progesterone therapy for preterm birth prevention (ie after 16 weeks gestation; first trimester use is not a contraindication).

Contact Information


Anna Bartholomew, RN
614-685-3229
Anna.Bartholomew@osumc.edu

Back